Who owns Senti Biosciences Holdings, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of SNTI from SEC Form 13F filings across 22 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 22 institutions disclosed 1.3M shares of Senti Biosciences Holdings, Inc. worth $418,371 — about 4.3% of shares outstanding; the largest disclosed holder is VANGUARD CAPITAL MANAGEMENT LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
22
13F holders
$418,371
value, 2026 filers
4.3%
of shares outstanding (1.3M sh)
5
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of SNTI's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | VANGUARD CAPITAL MANAGEMENT LLC | 537,504 | $167,701 | 0.0% | 1.7% | 0.0% |
| 2 | GEODE CAPITAL MANAGEMENT, LLC | 176,602 | $55,136 | 0.0% | 0.6% | -5.6% |
| 3 | TWO SIGMA SECURITIES, LLCNEW | 153,480 | $47,916 | 0.0% | 0.5% | new |
| 4 | GTS SECURITIES LLCNEW | 110,000 | $34,320 | 0.0% | 0.4% | new |
| 5 | VANGUARD FIDUCIARY TRUST CO | 91,193 | $28,452 | 0.0% | 0.3% | 0.0% |
| 6 | HRT FINANCIAL LPNEW | 53,827 | $16,000 | 0.0% | 0.2% | new |
| 7 | Virtu Financial LLC | 47,271 | $15,000 | 0.0% | 0.2% | +107.4% |
| 8 | Menlo Ventures Management, L.P. | 35,737 | $11,157 | 0.0% | 0.1% | 0.0% |
| 9 | NORTHERN TRUST CORP | 32,154 | $10,038 | 0.0% | 0.1% | 0.0% |
| 10 | SUSQUEHANNA INTERNATIONAL GROUP, LLPNEW | 23,147 | $7,226 | 0.0% | 0.1% | new |
| 11 | UBS Group AG | 17,402 | $5,430 | 0.0% | 0.1% | +20.6% |
| 12 | CITADEL ADVISORS LLC | 16,365 | $5,109 | 0.0% | 0.1% | -84.7% |
| 13 | XTX Topco Ltd | 14,885 | $4,647 | 0.0% | 0% | -37.0% |
| 14 | STATE STREET CORP | 10,010 | $3,125 | 0.0% | 0% | 0.0% |
| 15 | Nuveen, LLCNEW | 9,819 | $3,019 | 0.0% | 0% | new |
| 16 | Tower Research Capital LLC (TRC) | 8,959 | $2,797 | 0.0% | 0% | +22.0% |
| 17 | ROYAL BANK OF CANADA | 4,015 | $1,000 | 0.0% | 0% | 0.0% |
| 18 | SBI Securities Co., Ltd. | 523 | $163 | 0.0% | 0% | +56.6% |
| 19 | BlackRock, Inc. | 262 | $82 | 0.0% | 0% | -93.5% |
| 20 | MORGAN STANLEY | 160 | $50 | 0.0% | 0% | -5.3% |
| 21 | BARCLAYS PLC | 10 | $3 | 0.0% | 0% | -98.7% |
| 22 | Caitong International Asset Management Co., Ltd | 1 | $0 | 0.0% | 0% | 0.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.